Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy?

Related Experiment Video

Updated: May 18, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Chen Yao1, Jian-jun Wei, Zu-yu Wang

  • 1Department of Orthopedics, BenQ Medical Center, Nanjing Medical University, Nanjing, Jiangsu, China.

Cell Biochemistry and Biophysics
|September 28, 2012
PubMed

Insights

Perifosine effectively inhibits osteosarcoma cell growth and induces apoptosis by disrupting key signaling pathways. This agent shows potential as a novel therapeutic for osteosarcoma, even enhancing existing chemotherapy efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteosarcoma patients have a poor prognosis despite current adjuvant chemotherapy.
  • There is an urgent need for novel and more effective anti-osteosarcoma agents.

Purpose of the Study:

  • To investigate the efficacy of perifosine as an anti-osteosarcoma agent.
  • To elucidate the molecular mechanisms underlying perifosine's anti-tumor activity in osteosarcoma.

Main Methods:

  • Cultured human osteosarcoma cells were treated with perifosine.
  • Key signaling pathways including Akt/mTORC1, caspase-3, c-Jun N-terminal kinases (JNK), and p53 were analyzed.
  • Survivin expression and its association with heat shock protein-90 (HSP-90) were examined.
  • The effect of perifosine in combination with etoposide or doxorubicin was evaluated.

Main Results:

  • Perifosine induced significant apoptosis and growth inhibition in osteosarcoma cells.
  • Perifosine blocked Akt/mTORC1 signaling and promoted caspase-3, JNK, and p53 activation.
  • Perifosine disrupted the association between survivin and HSP-90, leading to decreased survivin expression.
  • Low-dose perifosine enhanced the anti-cancer activity of etoposide and doxorubicin.

Conclusions:

  • Perifosine demonstrates potent anti-osteosarcoma activity through multiple molecular mechanisms.
  • Perifosine warrants further investigation as a novel therapeutic agent for osteosarcoma.
  • Combination therapy with perifosine may improve treatment outcomes for osteosarcoma patients.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...